Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Zhi Ven Fong, M.D.

Co-Author

This page shows the publications co-authored by Zhi Ven Fong and Kenneth Tanabe.
Connection Strength

2.478
  1. ASO Author Reflections: Variations and Inconsistencies in the Guidelines for the Clinical Management of Cholangiocarcinoma. Ann Surg Oncol. 2021 12; 28(Suppl 3):860-861.
    View in: PubMed
    Score: 0.924
  2. The Clinical Management of Cholangiocarcinoma in the United States and Europe: A Comprehensive and Evidence-Based Comparison of Guidelines. Ann Surg Oncol. 2021 May; 28(5):2660-2674.
    View in: PubMed
    Score: 0.923
  3. The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review. Cancer. 2014 Sep 15; 120(18):2824-38.
    View in: PubMed
    Score: 0.579
  4. Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2019 Nov; 26(12):4091-4099.
    View in: PubMed
    Score: 0.052
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.